PR Newswire

• Cui Tiankai, former Chinese Ambassador to the United States: cognitive and narrative issues in Sino-US relations
• Professor Huang Renwei, Distinguished Vice President of China Institute for Innovation & Development Strategy, Executive Director-General, Fudan Institute for Belt and Road and Global Governance: the death of Henry Alfred Kissinger, former US secretary of state, inspired a new era in international relations

GUANGZHOU, China, Dec. 8, 2023 /PRNewswire/ -- The Understanding China Conference, a prestigious event hosted by China Institute for Innovation & Development Strategy, recently took place in Guangzhou, China. The conference, centered on China's New Endeavors Amid Unprecedented Global Changes—Expanding the Convergence of Interests and Building a Community of Shared Future, featured a keynote speech from Cui Tiankai, advisor to the Council of Chinese People's Institute of Foreign Affairs and former Chinese Ambassador to the United States, during the luncheon. The luncheon event was presided over by Zheng Yongnian, Chairman of the Guangzhou Guangdong Hong Kong Macao Greater Bay Area Research Institute and Dean of the Qianhai International Affairs Research Institute at the Chinese University of Hong Kong (Shenzhen).

Cui Tiankai underscored the necessity of a precise narrative to grasp China's essence. He highlighted three widespread mistaken acknowledgement about China's foreign policy: China's strategic global intentions, China's peripheral foreign policy, and China's diplomatic style. He also voiced his inclination to select "Sun Wukong" to epitomize China's diplomatic style, marked by loyalty, steadfastness, discernment of good and evil, potent capability, and distinct Chinese cultural aspects.

On November 29, before the conference, former US Secretary of State, Mr. Kissinger, passed away.

"Many people mentioned and commemorated him in their speeches at the Conference. His interest in global strategic stability and his expansive vision for world leadership are well-known," said Professor Huang Renwei, Distinguished Vice President of China Institute for Innovation & Development Strategy and Executive Director-General, Fudan Institute for Belt and Road and Global Governance.

"The passing of Mr. Kissinger has ushered in a new chapter in international relations. Kissinger often said that each visit to China brought fresh insights and knowledge. As a symbol of an era, his passing did not end that era; instead, sparked a new period in international relations."

Video - https://mma.prnewswire.com/media/2295421/video.mp4
Video - https://mma.prnewswire.com/media/2296319/Video2.mp4

View original content:https://www.prnewswire.co.uk/news-releases/the-2023-understanding-china-conference-china-narrative-challenges-and-opportunities-302009944.html

Clinical investigators complete enrollment in the 177 patient, randomized, controlled study, STAND (A Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in subjects with Arterial Disease Below the Knee, NCT03477604).

WILMINGTON, Mass., Dec. 6, 2023 /PRNewswire/ -- Micro Medical Solutions (MMS), an innovator in the field of microvascular intervention to improve clinical outcomes and quality of life in patients with CLI/CLTI, announced today that it has completed its U.S. pivotal clinical study enrollment evaluating the safety and effectiveness of the MicroStent System compared to the current standard of care, PTA (percutaneous transluminal angioplasty). The MicroStent System has already obtained CE Mark approval for use in the EEA.

STAND (A Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in subjects with Arterial Disease Below the Knee) enrolled its final patient earlier this month marking the completion of the study. MicroStent is a vascular stent specifically designed to achieve and maintain tibioperoneal arterial patency improving blood flow and wound healing for below-the-knee amputation reduction in patients with critical limb ischemia (CLI) resulting from progressive peripheral artery disease (PAD).

"I would like to thank the investigators and the research teams for their dedication, participation, collaboration and tremendous effort to help this complex and difficult patient population. I'm excited to continue to provide research expertise to the company and discuss the study results when available," said lead investigator, Dr. Robert E. Beasley of Palm Vascular Centers in Miami Beach, Florida.

"CLI/CTI is the most severe clinical manifestation of PAD. We are excited to see the data unfold to further understand the impact of angiosome directed endovascular intervention and its impact on wound healing, limb salvage and patient living independence. We are warmly appreciative to our patient population that participated in the study. The study's goal has always been to demonstrate a lower amputation rate thereby, lowering the devastating mortality rate associated with limb loss," commented Rita Jacob, Vice President of Clinical Affairs.

"This is an encouraging step forward for MMS, millions of patients battling CLI every day and Clinicians treating and caring for these patients," said CEO, Gregory Sullivan. "MMS developed the MicroStent platform in response to patients' needs, and we are excited to move closer to putting MicroStent in the hands of U.S. interventionalists treating CLI."

For more about Micro Medical Solutions, visit www.micromedicalsolutions.net.

Logo - https://mma.prnewswire.com/media/2293608/micromedical_solutions_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/micro-medical-solutions-announces-completion-of-enrollment-in-the-stand-pivotal-clinical-trial-302007621.html

~The new COO to steer innovation in the construction conglomerate's growth journey~

MUMBAI, India, Dec. 5, 2023 /PRNewswire/ -- Infra.Market, India's leading construction material company, has appointed Atul Sanghvi as the Chief Operating Officer for their Tiles, Bath Fittings & Sanitaryware division. Atul comes with an extensive and illustrious career spanning over four decades. A seasoned veteran in the construction material industry, he has demonstrated unwavering dedication, showcasing exceptional expertise with leadership skills.

On this strategic appointment, Aaditya Sharda, Co-Founder, Infra.Market said, "We are thrilled to welcome Atul as the distinguished leader guiding this division within IVAS at Infra.Market. His pivotal role will establish IVAS as a marquee brand in Tiles, Bath Fittings & Sanitaryware and a dominant force within the industry. His transformative vision and expertise instill confidence as we embark on elevating the business to the next level." 

He further added, "In the last one year, Infra.Market has strategically enhanced its talent pool by appointing industry stalwarts, solidifying our position at the forefront of the industry. These visionary leaders align with our commitment to innovation and will play a crucial role in steering us towards sustained success and growth." 

Before joining Infra.Market, he held key roles at ASTRAL Limited and Cera Sanitaryware Ltd., where he served for 22 years, progressing from GM (Sales & Marketing) to Executive Director & CEO. Furthermore, he contributed significantly as the General Manager (Marketing) at Grasim Industries Limited's Cement Division for 11 years.

Powered by Infra.Market, IVAS is the consumer brand dedicated to revolutionizing home construction and renovation. With a commitment to innovation and quality, IVAS aims to redefine the home construction landscape, providing a fresh and compelling approach to enhance living spaces.

About Infra.Market

Founded in 2016 and valued today at $2.5 billion, Infra.Market, India's foremost construction materials company, is reshaping the future of construction, both domestically and internationally. With innovative business planning and smart use of technology, it is the only company in the country to seamlessly supply over 15 different construction material product categories, including Concrete, AAC Blocks, Steel, Pipes & Fittings, MDF, Plywood, Laminates, Tiles, Bath Fittings & Sanitary, Fans, Lights, Kitchen and Electrical Appliances, Modular Kitchens & Wardrobes, Designer Hardware and even Paints.

Equipped with 10,000+ retail touchpoints and 30+ flagship stores, Infra.Market supplies all its products under its own brand name and also from companies that it has invested in including RDC Concrete and Shalimar Paints Ltd. Additionally, it has fortified its market position by launching India's first of its kind multi products and multi categories brand IVAS for home construction and renovation needs. The company takes pride in operating 200+ concrete manufacturing plants and an additional 30+ manufacturing units for other product categories. Fostering transparency and efficiency within the industry, most products supplied by Infra.Market are manufactured in-house.

Its distinctive fusion of conventional solutions with an unconventional, disruptive approach provides a comprehensive range of construction material products consolidated under one roof. This integrated approach efficiently caters to the diverse requirements of both B2B and B2C needs in the construction material industry.

Website: www.infra.market  
LinkedIn: https://www.linkedin.com/company/inframarket/  
Instagram: https://www.instagram.com/infra.market/  
Facebook: https://www.facebook.com/infra.market/  
X (Formerly Twitter): https://x.com/InfraMarket_?s=20

View original content:https://www.prnewswire.com/in/news-releases/inframarket-appoints-atul-sanghvi-as-chief-operating-officer-for-tiles-bath-fittings--sanitaryware-302005846.html

Working in concert with Ethic Ocean, the Association's World Culinary Council will lobby European ministers to protect biodiversity

PARIS, Dec. 5, 2023 /PRNewswire/ -- The members of Relais & Châteaux's World Culinary Council has voted to immediately remove eel from their own menus and are sending a call to action to the rest of the group's 580 hotels and restaurants to do the same, after its NGO partner Ethic Ocean launched an alert that public authorities must urgently listen to scientists who recommend suspending European eel fishing.

To view the Multimedia News Release, please click:
https://www.multivu.com/players/uk/9230451-relais-chateaux-chefs-pledge-stop-serving-eel-prevent-extinction/

The European eel (Anguilla anguilla), which is featured in menus all over the world–and revered in certain French, Spanish, Belgian, Dutch and Japanese culinary cultures–is considered critically endangered and features on the International Union for Conservation of Nature's (IUCN) Red List of Threatened Species. Over the last 20 years, European scientists from the International Council for the Exploration of the Sea (ICES) have been warning about all the causes of the alarming decline of this species–but for the last three years, they have recommended suspending fishing.

In this context, the 21 Relais & Châteaux chefs elected to the Association's World Culinary Council gathered in October and voted to approve an immediate ban of European eel from its menus. In partnership with Ethic Ocean, Relais & Châteaux calls on the 27 European Union ministers to hear this chef mobilization and scientific recommendation in order to take the necessary measures this December to safeguard this species.

The effort follows a similar approach taken by the Association, in 2009, to save the bluefin tuna (Thunnus thynnus) stocks in the North-East Atlantic Ocean and the Mediterranean Sea, which were close to collapsing. This action contributed to public mobilization around this species, which encouraged legislators to enact management measures adapted to the situation of the state of the stock.

A Variety of Issues

The situation with eels is very alarming because this species suffers from a numerous challenges including water pollution (particularly rivers), habitat destruction, dams that impede their biological cycle and illegal fishing, which has created a black market, fetching up to €5,000 per kilo. Eels are the only fish that are targeted at their juvenile stage, on top of the fact that it takes them a long time to reach reproductive maturity.

While it is urgent to suspend eel fishing today, it is crucial that the public authorities take the necessary measures to fight against the other causes of the decline of this species.

Mauro Colagreco, Vice President, Chefs of Relais & Châteaux and therefore leader of the World Culinary Council, and chef-owner of the three-Michelin-starred restaurant Mirazur in the South of France, said, "Chefs have a critical role to play: we can stop the demand. We have a chance to protect eels from becoming extinct, and of preserving biodiversity to allow future generations to continue to enjoy them, but only if we act now. As the world's largest network of chefs, Relais & Châteaux hopes to save this species."

Gastronomy: Dependent on Nature

The World Culinary Council–an international committee of 21 chefs from across the Relais & Châteaux network–had gathered over October 8-10, 2023, under the Association's president, Laurent Gardinier.

Laurent Gardinier said: "We have an acute understanding that Relais & Châteaux, and our very art de vivre, is dependent on nature. We must lead in sustainability to protect the ecosystems and biodiversity that our culinary and travel experiences rely on. It is these experiences that move our guests emotionally. And this would not be possible without nature."

A Vehicle for Change

The World Culinary Council wishes to draw attention to the plight of eels.

Relais & Châteaux has had a partnership with Ethic Ocean since 2009 and regularly unites its members around actions in favor of the environment, especially marine biodiversity (for example, World Oceans Day). 

Gilles Boeuf, president of Ethic Ocean, said, "I am happy to see the Relais & Châteaux association support this alert, which aims, above all, to preserve an exceptional species that reflects humanity's relationship with the environment. This cause to save the eel touches on many biodiversity issues. Let's act before it's too late."

To learn more about sustainability at Relais & Châteaux, the Association's annual report with 15 objectives for 2025 and 2030 can be found here:

https://www.relaischateaux.com/us/discover/commitments   

About Relais & Châteaux

A MOVEMENT WITH MEANING  

Relais & Châteaux, established in 1954, is an association of 580 unique hotels and restaurants throughout the world, owned and operated by independent entrepreneurs – most often families – who are passionate about their craft and deeply committed to forging warm, lasting relationships with their guests. Relais & Châteaux members protect and promote the wealth and diversity of the world's culinary and hospitality traditions, to ensure they continue to thrive. They are equally dedicated to preserving local heritage and the environment, as articulated in the association's Vision presented to UNESCO in November 2014.  

www.relaischateaux.com 

About Ethic Ocean 

Ethic Ocean is a non-governmental environmental organization dedicated to the conservation of fisheries and marine ecosystems. Its mission is to create opportunities for change and help implement sustainable practices in the fisheries industry. Ethic Ocean works with all stakeholders to help them source species having stocks that are not overfished or which have been farmed responsibly.

For more information, visit www.ethic-ocean.org. 

PRESS CONTACT

J/PR
relaisuk@jpublicrelations.com

Contact SCANDINAVIA
By Baungaard
email: tina@bybaungaard.com

Contact BENELUX
Pitch PR
email: dagmar@pitchpr.nl

LIST OF WORLD CULINARY COUNCIL CHEFS:

1.  Mauro Colagreco
Vice President, Chefs, Relais & Châteaux
Relais & Châteaux Mirazur, FRANCE

2.  Peter Tempelhoff
Chef Delegate, Africa & Indian Ocean,
Relais & Châteaux Ellerman House, SOUTH AFRICA

3.  Josep Espuga 
Chef Delegate, Australia, New Zealand & Pacific,
Relais & Châteaux Laura at Pt. Leo Estate, AUSTRALIA

4.  Jef Schuur
Chef Delegate, Benelux, Eastern Europe & Scandinavia,
Relais & Châteaux Bij Jef, THE NETHERLANDS

5.  Frédéric Doucet
Chef Delegate, France: Great East & Rhône-Alps,
Relais & Châteaux Maison Doucet, FRANCE

6.  Cédric Béchade
Chef Delegate, France: Great Southern West,
Relais & Châteaux L'Auberge Basque, FRANCE

7.  Mathieu Guibert
Chef Delegate, France: Great West,
Relais & Châteaux Anne de Bretagne, FRANCE

8.  Julien Dumas
Chef Delegate, France: Paris & Champagne,
Relais & Châteaux Saint James Paris, FRANCE

9.  Jacques Pourcel
Chef Delegate, France: Provence, French Riviera, Corsica & Languedoc,
Relais & Châteaux Hôtel Richer de Belleval, FRANCE

10.  Holger Bodendorf
Chef Delegate, Germany & Austria,
Relais & Châteaux Landhaus Stricker, GERMANY

11.  Vicky Lau
Chef Delegate, Greater China, Indian Subcontinent & Southeast Asia,
Relais & Châteaux Tate Dining Room, HONG KONG

12.  Emanuele Scarello
Chef Delegate, Italy,
Relais & Châteaux Agli Amici dal 1887, ITALY

13.  Shinichiro Takagi
Chef Delegate, Japan & Korea,
Relais & Châteaux Zeniya, JAPAN

14.  Marko Gajski
Chef Delegate, Mediterranean, Middle East & Morocco,
Relais & Châteaux Lešić Dimitri, CROATIA

15.  Jason Bangerter
Chef Delegate, North America: Canada,
Relais & Châteaux Langdon Hall, CANADA

16.  Gabriel Kreuther
Chef Delegate, North America: USA East & Caribbean,
Relais & Châteaux Gabriel Kreuther, NEW YORK, USA

17.  Kyle Connaughton
Chef Delegate, North America: USA West & Mexico,
Relais & Châteaux SingleThread Farm-Restaurant-Inn, CALIFORNIA, USA

18.  Norman Brandt
Chef Delegate, South America & Central America,
Relais & Châteaux Pikaia Lodge, GALÁPAGOS ISLANDS

19.  Pedro Subijana
Chef Delegate, Spain & Portugal,
Relais & Châteaux Akelarre, SPAIN

20.  Stéphane Décotterd
Chef Delegate, Switzerland & Liechtenstein,
Relais & Châteaux Restaurant Stéphane Décotterd, SWITZERLAND

21.  Michael Caines
Chef Delegate, United Kingdom & Ireland,
Relais & Châteaux Lympstone Manor, UNITED KINGDOM

Video - https://mma.prnewswire.com/media/2290486/Relais_Chateaux_chefs_pledge.mp4
Logo - https://mma.prnewswire.com/media/2084329/4433700/Relais_et_Chateaux_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/relais--chateaux-chefs-pledge-to-stop-serving-eel-with-immediate-effect-to-prevent-its-extinction-302005665.html

VICTORIA, Seychelles, Dec. 1, 2023 /PRNewswire/ -- Bitget, the world's leading cryptocurrency exchange and Web3 company, has announced the listing of CSIX, the native token of Carbon Browser - one of the fastest WEB3 browsers. The WEB3 browser token CSIX will be listed on Innovation Zone and Web3 Zone to expand Bitget's spot trading spectrum, offering its users access to emerging and community-driven digital assets.

Carbon Browser is an open-source, fast, private and secure Web3 browser developed by Carbon Browser X Labs. Launched in 2016 the product is developed on a customized version of Chromium, offering faster web browsing and better user security protection. Users can utilise their privacy-first features such as protection against ad-tracking, and higher performance with fast page loading, along with access to built-in crypto wallet and more. The browser has been designed to be user-friendly and accessible even to crypto beginners.

Carbon Browser is working on delivering an extensive WEB3 browser experience with integrated wallet, ability to store cryptocurrencies, swap and bridge functionalities. This includes Web3 applications such as crypto exchanges, NFT marketplaces, dApps, as well as Web2 applications such as ChatGPT.

"In the quest of providing easy access to high potential crypto ecosystems, we're focused on listing projects with real-world use cases. In this era of intense computer usage, browsers that give better output and performance will accelerate web3's adoption. With these types of listings, we provide a broader range of use cases for emerging tokens in Bitget's ecosystem," said Gracy Chen, Managing Director at Bitget.

Deposits for CSIX tokens are open now and trading in the spot market of the platform will be available from 11:00 December 4 (UTC). Upon listing, users can trade CSIX with 150+ cryptocurrencies on Bitget's industry-leading, fast, and secure trading platform. To buy trending and newly listed tokens such as CSIX users can use debit/credit cards, bank transfers and other multi-currency payment methods.  For more information on trading CSIX, please visit the official announcement.

About Bitget

Established in 2018, Bitget is the world's leading cryptocurrency exchange and Web3 company. Serving over 20 million users in 100+ countries and regions, the Bitget exchange is committed to helping users trade smarter with its pioneering copy trading feature and other trading solutions. Formerly known as BitKeep, Bitget Wallet is a world-class multi-chain crypto wallet that offers an array of comprehensive Web3 solutions and features including wallet functionality, swap, NFT Marketplace, DApp browser, and more. Bitget inspires individuals to embrace crypto through collaborations with credible partners, including legendary Argentinian footballer Lionel Messi and official eSports events organizer PGL. 

For more information, visit: Website  |  Twitter  |  Telegram  |  LinkedIn  | Discord | Bitget Wallet 

View original content:https://www.prnewswire.co.uk/news-releases/bitget-to-list-carbon-browser-csix-in-spot-market-and-innovation-zone-302003790.html

BEIJING, Dec. 2, 2023 /PRNewswire/ -- Beijing, the strong, fast-beating heart of Chinese prosperity, has been known as a safe and stable city free from natural calamities. But not the summer of 2023. Throughout the season, the mercury soared, with daily highs consistently hitting over 40°C. Then as the capital had a relative respite from sweltering heat, there came the heavy rain, flooding and displacing thousands of people.

As Beijing recovered, some horrible but similar trend is echoing all around the globe: the deadliest U.S. wildfire in more than a century scorched Lahaina, Hawaii; the devastating floods that destroyed a quarter of the city of Derna, Lybia; extreme heat and worsen drought in Chile and the Horn of Africa; rising sea level for island countries... "Humanity has opened the gates of hell," as the UN Secretary-General António Guterres noted, "we are heading towards a dangerous and unstable world."

Although the alarm bell keeps ringing, we should not lose hope and give up. But rather, it's high time to take actions. China and the United States, as the world's two largest economies, have shown their political will by the milestone Sunnylands Statement. And looking back a bit further, from the Kyoto Protocol to the Paris Agreement, binding targets to limit emission and temperature increase have been set through joint efforts.

And China has walked the talk for achieving its goal of carbon peaking and neutrality. From transforming deserts to cleaning up the air, to developing new technology, shifting energy structure, and raising public awareness on a healthier lifestyle. China is doing everything to cultivate a more sustainable cycle of nature, to pay off previous ecological debts, avoid new debts, and strive to save our planet in more creative ways.

If climate change is a global concern, the burden is not equally shared. On the one hand, developed countries are responsible for most of the heat-trapping emissions since the Industrial Revolution. On the other, developing countries have lower emissions, but are bearing the brunt of a hotter climate. Promises from some of the world's biggest economies haven't been panning out, delayed by political deadlock, bureaucratic hurdles and debates over new rules to expedite aid from development banks and private donors.

An injustice burns at the heart of the climate crisis and its flame is scorching hopes and possibilities, as world leaders are warning. "We cannot continue," Mia Mottley, Prime Minister of Barbados called, "to put the interest of a few before the lives of many."

How to make sure the whole is greater than the sum of its parts, with all pulling in the same direction? It needs leadership, vision, and multilateralism. China, along with the rest of the world, is taking the lead to give its best shot, bringing down the price of renewable energy, sharing knowhow for deploying sustainable projects, and transitioning to a low-carbon era. With climate change being a global issue, only in a global approach and by joint efforts can we translate the will into concrete outcomes, and mitigate the climate we changed.

Video - https://www.youtube.com/watch?v=vq3bkp6DsUY

View original content:https://www.prnewswire.co.uk/news-releases/cgtn-on-climate-change-were-running-out-of-time-not-options-302003782.html

DUBAI, UAE, Dec. 1, 2023 /PRNewswire/ --

• Masdar, the UAE's clean energy powerhouse, to acquire 49 percent stake in RWE's 3GW Dogger Bank South (DBS) offshore wind projects, as part of £11billion investment in UK's renewables sector
• One of world's largest offshore wind development projects, DBS is set to power up to 3 million British homes, boost the UK economy and create thousands of jobs
• Deal signed during COP28 in UAE shows commitment of Masdar, whose Chairman is also COP28 President, to invest in accelerating net zero in UK and Europe by harnessing region's huge offshore wind potential

Abu Dhabi Future Energy Company PJSC – Masdar, the UAE's clean energy powerhouse, is part of an £11billion investment into the UK's renewable energy sector and is purchasing a 49 percent stake in RWE's 3 gigawatt (GW) Dogger Bank South (DBS) projects - which form one of the world's largest planned offshore wind farms. DBS is capable of powering millions of British homes, reducing emissions and creating up to 3,000 jobs. Closing of the transaction is subject to customary approvals and expected in the first quarter of 2024.

The agreement was signed on the sidelines of the UN's climate change conference COP28, in the UAE. The £11billion joint investment will provide a huge boost to the UK economy and demonstrates the UAE's long-term commitment to supporting net-zero goals in Britain and around the world. It builds on the £10 billion UAE-UK Sovereign Investment Partnership (UK-UAE SIP) to invest in technology, infrastructure and the energy transition.

The 3GW DBS projects bring together global clean energy pioneers Masdar and RWE, a leading renewable energy company headquartered in Germany. The mega-facility is expected to generate enough energy to power 3 million typical UK homes. The projects are predicted to create 2,000 jobs during construction and more than 1,000 direct and indirect jobs during their operational phase.

Masdar Chief Executive Officer, Mohamed Jameel Al Ramahi, and the Chief Executive Officer of RWE, Dr Markus Krebber, signed the agreement at COP28 in Expo City Dubai, on December 1.

Located over 100 kilometers off the northeastern coast of England, the DBS offshore wind farms will be split across two sites, the DBS East Array and the DBS West Array. Each site will have the capacity for 1.5GW and span 500 square kilometers. Masdar will acquire a 49% stake in the landmark renewables project while RWE, with a 51% share, will remain in charge of development, construction and operation throughout the life cycle of the projects.

The construction phase could start as early as end 2025 and the first 800MW of electricity is planned to come online in 2029. The DBS projects are expected to be fully commissioned by end of 2031.

HE Dr Sultan Al Jaber, UAE Minister of Industry and Advanced Technology, Chairman of Masdar and COP28 President, said: "As one of the world's largest offshore wind farms, the Dogger Bank South project will make a huge impact on reducing emissions while supplying millions of UK families and businesses with clean, affordable and secure energy.  The world needs to triple renewable energy capacity and double energy efficiency by 2030 if we are to keep the Paris Agreement goal of limiting temperature rises to 1.5 degrees within reach.  At COP28, as we strive to form a unified plan to deliver the urgent course correction the planet needs, projects such as DBS show how nations, companies and communities can join forces to deliver powerful solutions. It also shows the deep bonds between the UK and UAE as exemplified by the UAE-UK Sovereign Investment Partnership, which was expanded to commit £10 billion investments in technology, infrastructure, and the energy transition during President His Highness Sheikh Mohamed bin Zayed Al Nayhan's visit to Britain in 2021."

Masdar's Chief Executive Officer, Mohamed Jameel Al Ramahi, said: "Masdar is very proud to be partnering with RWE to develop one of the world's largest offshore wind farms. We are delighted to have come onboard at the early stages of this pioneering project, enabling us to leverage our shared passion and expertise in renewables. The UK is the world's second largest offshore wind market and offers huge growth potential. Masdar has been active in the UK for more than a decade, developing world-class clean energy projects such as Dogger Bank South which demonstrate how innovation and collaboration can lead to a cleaner, greener future. As global leaders strive to form a unified and urgent plan to tackle the climate crisis at COP28, Masdar will continue to expand its wind energy portfolio as we target a total global capacity of 100GW by 2030 in support of key climate goals." 

The deal demonstrates Masdar's long-standing commitment to advancing offshore wind projects in the UK and Europe. A decade ago, Masdar, RWE and its partners launched the 630MW London Array wind farm, the world's largest at the time. Today's investment in the 3GW DBS projects - almost five times as big as London Array - shows Masdar's steadfast expansion into the exciting offshore wind sector. Masdar has also invested in the 30MW Hywind project, which was the world's first floating offshore wind farm, and the 402MW Dudgeon offshore wind farm. In July, Masdar invested in the 476MW Baltic Eagle offshore wind farm set to power 475,000 homes. The company's Global Offshore Wind division is based in London and Masdar is pursuing a strategy of investing and developing projects at the early stages to further strengthen its expertise as an offshore wind developer.

Markus Krebber, CEO RWE AG: "We're delighted to welcome Masdar onboard as our partner and co-investor in the delivery of our Dogger Bank South projects which, at 3GW in size, make up RWE's largest offshore wind development in the UK. With Masdar, we have a strong and renowned partner at our side who shares our ambition to further drive the growth of offshore wind energy. In combination with RWE's many years of experience in the development, construction and operation of offshore wind farms, we are in an excellent position to strongly support the decarbonization of the UK."
Offshore wind energy could generate 380GW by 2030, provided investment is increased and permitting protocols are accelerated, according to the International Renewable Energy Agency. With the UK and Europe setting ambitious legally binding net-zero goals, Masdar will continue to harness opportunities to develop the region's burgeoning wind energy sector.

RWE is leading the way to a green energy world. Between 2024 and 2030, RWE will invest 55 billion euros worldwide in offshore and onshore wind, solar energy, batteries, flexible generation, and hydrogen projects. By the end of the decade, the company's green portfolio will grow to more than 65 gigawatts of generation capacity, which will be perfectly complemented by global energy trading. RWE is decarbonizing its business in line with the 1.5-degree reduction pathway and will phase out coal by 2030. RWE will be net zero by 2040.

RWE is already one of the leading companies in the field of renewable energy and offshore wind. Its unparalleled expertise over the last 20 years has resulted in 19 offshore wind farms in operation, with a goal to grow its global offshore wind capacity from 3.3GW today to 10GW in 2030.

About Masdar
Abu Dhabi Future Energy Company (Masdar) is the UAE's clean energy champion and one of the fastest growing companies in the world, advancing the development and deployment of renewable energy and green hydrogen technologies to address global sustainability challenges. Established in 2006, Masdar has developed projects in over 40 countries, helping them to achieve their clean energy objectives and advance sustainable development. Masdar is jointly owned by Abu Dhabi National Oil Company (ADNOC), Mubadala Investment Company (Mubadala), and Abu Dhabi National Energy Company (TAQA), and under this ownership the company is targeting a renewable energy portfolio capacity of at least 100 gigawatts (GW) by 2030 and an annual green hydrogen production capacity of up to 1 million tonnes by the same year.

For more information please visit: http://www.masdar.ae and connect: facebook.com/masdar.ae and twitter.com/masdar

This material is distributed by Daniel J. Edelman, Inc. on behalf of Masdar. Additional information is available at the Department of Justice, Washington, DC.

Photo - https://mma.prnewswire.com/media/2290783/Masdar_signing.jpg
Logo - https://mma.prnewswire.com/media/1973446/4410562/Masdar_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/masdar-joins-forces-with-rwe-in-11-billion-investment-to-co-develop-massive-3gw-offshore-wind-projects-in-uk-302003569.html

Experts from across Latin America explore how to improve access to recommended treatment practices based on the latest international guidelines.

BUENOS AIRES, Argentina and PLYMOUTH MEETING, Pa., Nov. 30, 2023 /PRNewswire/ -- Today the Latin American and Caribbean Society of Medical Oncology (SLACOM) and National Comprehensive Cancer Network^® (NCCN^®) host the Latin American Regional Breast Cancer Summit: Advocating and Implementing Guideline-Concordant Cancer Care for Patients. Esteemed experts from Argentina, Brazil, Mexico, Columbia, Peru, and the United States will present challenges, barriers, and potential solutions for improving access to guideline-concordant breast cancer care in the Latin American region. The regional summit provides an opportunity for a diverse group of multidisciplinary experts to identify and fill any knowledge gaps in breast cancer care and health system processes for cancer prevention and control in Latin America.

Visit NCCN.org/global for cancer treatment resources that have been tailored for specific regions or translated into Spanish, Portuguese, and other languages.

"There is a clear and urgent need to improve our current processes and systems, including those that guide patients in navigating health systems in Latin America," said Eduardo L. Cazap, MD, PhD, Founder and First President of SLACOM. "We hope that the findings and recommendations from the SLACOM/NCCN Working Group, as well as the feedback from the Latin American Regional Breast Cancer Summit will inform the development of Implementation Guidelines for Breast Cancer that can be used by patients, physicians, and systems to take action to address the needs of patients."

SLACOM and NCCN first launched a project to convene thought leaders, government entities, health care providers, patients, and civil society members to conduct a rigorous analysis of cancer burden, existing guidelines and healthcare utilization and accessibility, gaps, obstacles, and system disruptions to guideline-concordant care in Argentina in 2022. The SLACOM/NCCN Working Group developed a set of findings and recommendations to address the major impediments to guideline implementation in breast cancer care, which were presented and discussed at the summit.

That summit also included a presentation outlining the World Health Organization (WHO) Global Breast Cancer Initiative Implementation Framework to provide a practical model to help inform the work of the group moving forward.

"We are honored to continue working alongside SLACOM and others in the Latin America region," said Wui-Jin Koh, MD, Chief Medical Officer, NCCN. "People with cancer everywhere should have access to treatment based on established evidence-based, expert consensus guidelines. Today's webinar is part of the SLACOM/NCCN Working Group's ongoing commitment to develop procedures that improve the implementation of best practices in this region, according to the latest international standards."

NCCN has previously collaborated with other groups in the Latin American region and translated resources for patients and health care providers into Spanish and other languages. Learn more about how the gold standard NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) have been adapted for various locations and resource levels worldwide at NCCN.org/global.

About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network^® (NCCN^®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients^® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation^®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.

Media Contact:
Rachel Darwin
267-622-6624
darwin@nccn.org

Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/nccn-and-slacom-host-international-symposium-to-improve-breast-cancer-care-in-latin-america-301996263.html

AI will not take all jobs nor end civilization. But it will help businesses make better decisions.

CARY, N.C., Nov. 30, 2023 /PRNewswire/ -- Artificial intelligence (AI) is everywhere. And stories are rampant about its promise and its threat. Will AI's potential be realized in the year ahead? SAS, the leader in AI and analytics, asked executives and experts across the company to predict trends and key business and technology developments in AI for 2024. Below are some of the predictions they shared.

Visit SAS' 2024 AI predictions page for more trends and forecasts.

Generative AI will augment (not replace) a comprehensive AI strategy
"Generative AI technology does a lot of things, but it can't do everything. In 2024, organizations will pivot from viewing generative AI as a stand-alone technology to integrating it as a complement to industry-specific AI strategies. In banking, simulated data for stress testing and scenario analysis will help predict risks and prevent losses. In health care, that means the generation of individualized treatment plans. In manufacturing, generative AI can simulate production to identify improvements in quality, reliability, maintenance, energy efficiency and yield."
– Bryan Harris, Chief Technology Officer, SAS
[Note: Earlier this year, SAS committed $1 billion to AI-powered industry solutions.]

AI will create jobs
"In 2023, there was a lot of worry about the jobs that AI might eliminate. The conversation in 2024 will focus instead on the jobs AI will create. An obvious example is prompt engineering, which links a model's potential with its real-world application. AI helps workers at all skill levels and roles to be more effective and efficient. And while new AI technologies in 2024 and beyond may cause some short-term disruptions in the job market, they will spark many new jobs and new roles that will help drive economic growth."
– Udo Sglavo, Vice President of Advanced Analytics, SAS

AI will enhance responsible marketing
"As marketers we must consciously practice responsible marketing. Facets of this are awareness of the fallibility of AI and alertness to possible bias creeping in. While AI offers the promise of enhanced marketing and advertising programs, we know that biased data and models beget biased results. In SAS Marketing, we are implementing model cards that are like an ingredient list, but for AI. Whether you create or apply AI, you are responsible for its impact. That's why all marketers, regardless of technical know-how, can review the model cards, validate that their algorithms are effective and fair, and adjust as needed."
– Jennifer Chase, Chief Marketing Officer, SAS

Financial firms will embrace AI amid a Dark Age of Fraud
"Even as consumers signal increased fraud vigilance, generative AI and deepfake technology are helping fraudsters hone their multitrillion-dollar craft. Phishing messages are more polished. Imitation websites look stunningly legitimate. A crook can clone a voice with a few seconds of audio using simple online tools. We are entering the Dark Age of Fraud, where banks and credit unions will scramble to make up for lost time in AI adoption – incentivized, no doubt, by regulatory shifts forcing financial firms to assume greater liability for soaring APP [authorized push payment] scams and other frauds."
– Stu Bradley, Senior Vice President of Risk, Fraud and Compliance Solutions, SAS

Shadow AI will challenge CIOs
"CIOs have struggled with 'shadow IT' in the past and will now confront 'shadow AI' – solutions used by or developed within an organization without official sanction or monitoring by IT. Well-intentioned employees will continue to use generative AI tools to increase productivity. And CIOs will wrestle daily with how much to embrace these generative AI tools and what guardrails should be put in place to safeguard their organizations from associated risks."
– Jay Upchurch, Chief Information Officer, SAS

Multimodal AI and AI simulation will reach new frontiers
"The integration of text, images and audio into a single model is the next frontier of generative AI. Known as multimodal AI, it can process a diverse range of inputs simultaneously, enabling more context-aware applications for effective decision making. An example of this will be the generation of 3D objects, environments and spatial data. This will have applications in augmented reality [AR], virtual reality [VR], and the simulation of complex physical systems such as digital twins."
– Marinela Profi, AI/Generative AI Strategy Advisor, SAS

Digital-twin adoption will accelerate
"Technologies like AI and IoT [Internet of Things] analytics drive important sectors of the economy, including manufacturing, energy and government. Workers on the factory floor and in the executive suite use these technologies to transform huge volumes of data into better, faster decisions. In 2024, the adoption of AI and IoT analytics will accelerate through broader use of digital-twin technologies, which analyze real-time sensor and operational data and create duplicates of complex systems like factories, smart cities and energy grids. With digital twins, organizations can optimize operations, improve product quality, enhance safety, increase reliability and reduce emissions."
– Jason Mann, Vice President of IoT, SAS

Insurers will confront climate risk, aided by AI
"After decades of anticipation, climate change has transformed from speculative menace to genuine threat. Global insured losses from natural disasters surpassed $130 billion in 2022, and insurers worldwide are feeling the squeeze. US insurers, for example, are under scrutiny for raising premiums and withdrawing from hard-hit states like California and Florida, leaving tens of millions of consumers in the lurch. To survive this crisis, insurers will increasingly adopt AI to tap the potential of their immense data stores to shore up liquidity and be competitive. Beyond the gains they realize in dynamic premium pricing and risk assessment, AI will help them automate and enhance claims processing, fraud detection, customer service and more."
– Troy Haines, Senior Vice President of Risk Research and Quantitative Solutions, SAS 

AI importance will grow in government
"The workforce implications of AI will start being felt in government. Governments have a hard time attracting and retaining AI talent since experts command such high salaries, however, they will aggressively recruit for expertise to support regulatory actions. And like enterprises, governments will also increasingly turn to AI and analytics to boost productivity, automate menial tasks and mitigate that talent shortage."
– Reggie Townsend, Vice President of the SAS Data Ethics Practice

Generative AI will bolster patient care
"To advance health and improve patient and member experiences, organizations will further develop generative AI-powered tools in 2024 for personalized medicine, such as the creation of patient-specific avatars for use in clinical trials and the generation of individualized treatment plans. Additionally, we will see the emergence of generative AI-based systems for clinical decision support, delivering real-time guidance to payers, providers and pharmaceutical organizations."
– Steve Kearney, Global Medical Director, SAS

Deliberate AI deployment will make or break insurers
"In 2024, one of the top 100 global insurers will go out of business as a consequence of deploying generative AI too quickly. Right now, insurers are rolling out autonomous systems at breakneck speed with no tailoring to their business models. They're hoping that using AI to crunch through claims quickly will offset the last few years of poor business results. But after 2023's layoffs, remaining staff will be spread too thin to enact the necessary oversight to deploy AI ethically and at scale. The myth of AI as a cure-all will trigger tens of thousands of faulty business decisions that will lead to a corporate collapse, which may irreparably damage consumer and regulator trust."
– Franklin Manchester, Global Insurance Strategic Advisor, SAS

Public health will get an AI boost from academia
"Public health is achieving technologic modernization at an unprecedented rate. Whether overdoses or flu surveillance, using data to anticipate public health interventions is essential. Forecasting and modeling are rapidly becoming the cornerstone of public health work, but government needs help. Enter academia. We will see an increase in academic researchers carrying out AI-driven modeling and forecasting on behalf of government. It is clear after COVID-19 that the protection of our population will require exceptional technology and collaboration."
– Dr. Meghan Schaeffer, National Public Health Advisor and Epidemiologist, SAS

Want more?
This spring, you can talk with SAS executives about their predictions and explore the latest in AI and analytics. Join business leaders and analytics experts for SAS Innovate, April 16-19, 2024, in Las Vegas. Sign up today for updates on the conference and early-bird pricing.

About SAS
SAS is a global leader in AI and analytics software, including industry-specific solutions. SAS helps organizations transform data into trusted decisions faster by providing knowledge in the moments that matter. SAS gives you THE POWER TO KNOW^®.

SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. ® indicates USA registration. Other brand and product names are trademarks of their respective companies. Copyright © 2023 SAS Institute Inc. All rights reserved.

Editorial Contact:
Mike Nemecek 
SAS
mike.nemecek@sas.com
919-531-5140
sas.com/news

Video - https://mma.prnewswire.com/media/2288686/SAS_AI_predictions_2024_video.mp4

Photo - https://mma.prnewswire.com/media/2288685/SAS_AI_predictions_2024.jpg

Logo - https://mma.prnewswire.com/media/1250367/4429871/SAS_v1_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/ai-reality-vs-myth-twelve-predictions-from-sas-for-2024-302001272.html

BENGALURU, India, Nov. 30, 2023 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the integration of the Viatris' biosimilars business in 31 European countries has been successfully completed.

Following the acquisition of substantially all of the global biosimilar business of Viatris in November 2022, and the related integration of over 70 emerging market countries in July 2023 and North America in September 2023, the full transition of Viatris' biosimilars operations to Biocon Biologics Ltd in Europe represents another significant milestone as a world-leading biosimilars company.

In Europe, Biocon Biologics portfolio includes 7 biosimilars: Insulin Aspart and Insulin Glargine, Bevacizumab, Pegfilgrastim, Trastuzumab, Adalimumab, and Etanercept. At a global level, Biocon Biologics has a robust pipeline of 20 assets for diabetology, oncology, immunology, ophthalmology, and bone health. Serving over 5.7M patients annually, the Company is committed to providing access to high-quality therapies and solutions to patients, healthcare systems and governments across the globe.

Shreehas Tambe, CEO & Managing Director, Biocon Biologics Ltd, said: "The integration of the Viatris' biosimilar business in Europe ahead of schedule is another important milestone for Biocon Biologics in our journey as a global biosimilars leader. We are pleased to expand access to life-saving treatments for patients across Europe. Our unique, fully integrated capabilities and robust pipeline of 20 products will allows us to better address patient needs and be a reliable partner to health organisations."

Jozef Belcik, Head of Commercial Europe & JANZ, Biocon Biologics Ltd, said: "We are extremely pleased to have reached this historic moment and we are proud to lead the way in the advancement of biosimilars. As we continue to drive innovation and invest in the future, our mission is singularly focused on the development, manufacturing, distribution, and commercialization of biosimilars in Europe and in the world."

After the acquisition from Viatris, Biocon Biologics and its partners will commercialize biosimilar products in the following countries: Albania, Austria, Belgium, Bosnia, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, and The United Kingdom.

Note about biosimilars:
Based on IQVIA White Paper "The impact of biosimilar competition in Europe, IQVIA (2022)", as of 2022, the cumulative savings at list prices from the impact of biosimilar competition in Europe reached over €30 billion. Furthermore, since the launch of biosimilars these provided nearly 4.5 billion patient treatment days to European patients.
Source: 
^1-The impact of biosimilar competition in Europe, IQVIA (2022)
 December 2022. https://www.iqvia.com/-/media/iqvia/pdfs/library/white-papers/the-impact-of-biosimilar-competition-in-europe-2022.pdf

About Biocon Biologics Limited:

Biocon Biologics Ltd. (BBL), a subsidiary of Biocon Ltd., is a unique, fully integrated, global biosimilars company committed to transforming healthcare and transforming lives by enabling affordable access to high quality biosimilars for millions of patients worldwide. It is leveraging cutting-edge science, innovative tech platforms, global scale manufacturing capabilities and world-class quality systems to lower costs of biological therapeutics while improving healthcare outcomes.

BBL has acquired substantially all of the global biosimilars business of its long-standing partner Viatris, which is a historic milestone in its value creation journey. Biocon Biologics has commercialized eight biosimilars in key emerging markets and advanced markets like U.S., Europe, Australia, Canada, and Japan.

The Company has a pipeline of 20 biosimilar assets across diabetology, oncology, immunology, ophthalmology, and other non-communicable diseases. It has many 'firsts' to its credit in the biosimilars industry. As part of its environmental, social and governance (ESG) commitment, BBL is advancing the health of patients, people, and the planet to achieve key UN Sustainable Development Goals (SDGs). Website: www.bioconbiologics.com; Follow us on LinkedIn: Biocon Biologics ; Twitter: @BioconBiologics for company updates.

Biocon Limited, publicly listed in 2004, (BSE code: 532523, NSE Id: BIOCON, ISIN Id: INE376G01013) is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets as well as Generic Formulations in the US, Europe & key emerging markets. It also has a pipeline of promising novel assets in immunotherapy under development. Website: www.biocon.com; Follow-us on Linked In: Biocon Limited; Twitter: @bioconlimited for company updates.

Forward -Looking Statements: Biocon

This press release may include statements of future expectations and other forward-looking statements based on management's current expectations and beliefs concerning future developments and their potential effects upon Biocon and its subsidiaries/ associates. These forward-looking statements involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Important factors that could cause actual results to differ materially from our expectations include, amongst other: general economic and business conditions in India and overseas, our ability to successfully implement our strategy, our research and development efforts, our growth and expansion plans and technological changes, changes in the value of the Rupee and other currency changes, changes in the Indian and international interest rates, change in laws and regulations that apply to the Indian and global biotechnology and pharmaceuticals industries, increasing competition in and the conditions of the Indian and global biotechnology and pharmaceuticals industries, changes in political conditions in India and changes in the foreign exchange control regulations in India. Neither Biocon, nor our Directors, or any of our subsidiaries/associates assume any obligation to update any particular forward-looking statement contained in this release.

Logo - https://mma.prnewswire.com/media/2143906/Biocon_Biologics_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/biocon-biologics-successfully-completes-integration-of-viatris-biosimilar-business-in-31-countries-in-europe-302001922.html